Keywords: macusight, initiates, 30-patient, sirolimus, trial, usa-based, developer

MacuSight initiates 30-patient sirolimus trial

Article | 06 November 2006

Print This

MacuSight, a USA-based developer of therapeutics for the treatment of severe ocular conditions, has initiated a Phase I study of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in